Real-World Data Show Patients With T2D Reducing A1C With FreeStyle Libre
June 10th 2019Patients with type 2 diabetes (T2D) who had been using insulin an average of 8 years and had mean glycated hemoglobin (A1C) levels of 8.9% were able to bring their levels down 0.9% after 3 months, according to chart review data from 3 European countries.
Read More
Horizon and Aetion Partner to Optimize Treatment Pathways and Cut Healthcare Costs
June 7th 2019Aetion announced the company partnered with Horizon Healthcare Services to identify high-risk patients and optimal treatment pathways as a means to achieve better health outcomes and cut healthcare costs.
Read More
Few At-Risk Adults Are Being Referred to Diabetes Prevention Programs, Study Finds
April 27th 2019The CDC created the National Diabetes Prevention Program following a study of a lifestyle intervention; new results show that more than a third of adults who are referred to a program take part, but only a fraction are referred.
Read More
CGM Linked to Low A1C Among Blog Readers With Type 1 Diabetes
April 24th 2019The study by researchers at Penn State College of Medicine found those with type 1 diabetes who read blogs had lower glycated hemoglobin (A1C) levels, and the combination of reading blogs and using continuous glucose monitoring produced the best glycemic control.
Read More
CREDENCE: Canagliflozin Cuts Risk of Renal Failure, Death 30% in Patients With Type 2 Diabetes, CKD
April 15th 2019Results of the landmark study, the first in a series of renal outcomes studies for SGLT2 inhibitors, will be of great interest to policy makers given the cost of dialysis to Medicare.
Read More
As Comorbidities Pile Up, True Diabetes Cost Measured by More Than Insulin, Panel Says
April 14th 2019For endocrinologists, a cardiologist, a diabetes educator, and a room full of fellow health workers, the cost of doing nothing—not just to treat diabetes, but also to prevent it— is what feeds into the exorbitant cost of the disease, according to presentations and a panel at the inaugural meeting of the Institute for Value Based Medicine (IVBM) in Diabetes, an initiative of The American Journal of Managed Care®.
Read More
Continuous Glucose Monitoring: An Emerging Standard of Care
March 31st 2019The potential value of continuous monitoring of blood glucose and the enzyme-based electrode that underlies continuous glucose monitoring (CGM) in the subcutaneous tissue were described in the 1960s. In 1999, the FDA approved the first “professional” CGM system, which stored data over 3 days for later retrieval and analysis. However, many patients (even volunteers in CGM-based clinical trials) found early-generation systems uncomfortable and difficult to wear. By contrast, current systems are more accurate, provide customizable alerts and alarms, are easier to use and less likely to cause skin irritation, resist interference from acetaminophen, allow for real-time data to be shared and remotely monitored, and are stable enough so as not to require periodic calibrations with SMBG values.
Read More
A New Era: Increasing Continuous Glucose Monitoring Use in Type 2 Diabetes
March 31st 2019Continuous glucose monitors (CGMs) are increasingly accessible and effective for patients with type 2 diabetes (T2D), and even those with prediabetes, as a means for real-time biofeedback and behavior change.
Read More
FreeStyle Libre CGM Sees Rising Use With Pharmacy Chain Distribution
March 31st 2019When the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring (CGM) system in September 2017, diabetes advocates hailed the move as long overdue and one that might lead to greater penetration of glucose monitoring technology for those with type 2 diabetes.
Read More
Bariatric Surgery Study Shows Potential of Using CGM in Clinical Research
March 30th 2019In 2017, as advocates and researchers discussed the potential for continuous glucose monitoring (CGM) to become a tool in clinical trials, most of the discussion involved testing in new therapies. The discussion culminated in an international consensus on CGM, published in December 2017, that included standards for assessing hypoglycemia in clinical trials.
Read More
Three years after results from a study in Diabetes Care revealed how flaws in CMS’ Competitive Bidding Program endangered Medicare patients who rely on supplies to test their blood glucose, the federal government has allowed contracts to expire for the dwindling number of suppliers, raising fears that the program for seniors with diabetes has reached the point of collapse.
Read More
Relationship Between Heart Failure and Diabetes Seen Throughout ACC Sessions
March 18th 2019More than a decade after an FDA mandate for cardiovascular outcomes trials, cardiologists say insights gained on how 2 new drug classes affect heart failure in diabetes should be used to prevent complications. Several sessions at the 68th Scientific Session of the American College of Cardiology addressed this topic.
Read More
CGM Shows When Bariatric Surgery Patients Need Diabetes Therapy Adjustments
February 15th 2019The study used the Freestyle Libre to track blood glucose levels in patients with and without type 2 diabetes (T2D) who had different surgical procedures; the CGM showed a drop in glucose on the third day after surgery among patients with T2D who had gastric bypass.
Read More
FDA to Review SGLT1/2 Inhibitor Sotagliflozin as Possible Treatment for Type 1 Diabetes
May 24th 2018Clinical trial data has shown that the drug helped 28.6% of patients achieve glycated hemoglobin of 7.0% of less by week 24 without severe hypoglycemia or diabetic ketoacidosis and also helped participants lose weight.
Read More
Great Recession Had Negative Impact on Blood Pressure, Glucose, Study Finds
March 12th 2018The Great Recession was associated with increased blood pressure and glucose levels, especially among groups of older homeowners and individuals younger than 65 years still employed, according to new research published in Proceedings of the National Academy of Sciences. Medication use fell after the Great Recession, and the results provide strong evidence that economic crises can have measurable effects on public health.
Read More